Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00626808 · ClinicalTrials.gov registry record
A Post Marketing Evaluation of the Effectiveness of FluMist Risk Minimization Plan in Children
A clinical trial, sponsored by MedImmune.
- Completed
- Registry status
- 321,697
- Enrollment target
NCT00626808: Completed study, sponsored by MedImmune.
NCT00626808 is a clinical trial that has completed, run by MedImmune. The registered enrollment target is 321,697 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00626808 has completed, sponsored by MedImmune.
- COMPLETED
- Registry status
- 321,697 participants
- Enrollment target
Study Summary
This is a retrospective cohort study of children included in a large medical insurance claims database.
Primary Outcome
Among participants up to 59 months of age who received any flu vaccine, number who received FluMist
Interventions
- DRUG No Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 321,697 participants |
| Start Date | 2007-10 |
| Est. Completion | 2010-03 |
What the finished NCT00626808 record still lists
NCT00626808 is an observational study that tracks outcomes without assigning an intervention. Its 321,697 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which No Intervention is the first listed.
NCT00626808 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00626808 about?
NCT00626808 is a clinical study titled "A Post Marketing Evaluation of the Effectiveness of FluMist Risk Minimization Plan in Children". This is a retrospective cohort study of children included in a large medical insurance claims database.
What is the current status of trial NCT00626808?
This trial is currently completed. The enrollment target is 321,697 participants. The study started on 2007-10. Estimated completion is 2010-03.
What interventions are being tested in trial NCT00626808?
The interventions under investigation include: No Intervention (DRUG).
Who is sponsoring clinical trial NCT00626808?
This trial is sponsored by MedImmune, which has 210 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05668637 · 318,542 participants
Evaluation and Further Development of an Artificial Intelligence-based Algorithm for Clinical Decision Support
- NCT05365048 · 301,201 participants · NA
Provider Recommendation and HPV Vaccination
- NCT02280733 · 300,000 participants
A Real-World Registry of Chronic Wounds and Ulcers
- NCT06694181 · 300,000 participants
Safe and Explainable AI
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia